Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136760947> ?p ?o ?g. }
- W3136760947 endingPage "1424" @default.
- W3136760947 startingPage "1424" @default.
- W3136760947 abstract "Immuno-oncology (IO) agents (anti–programmed cell death 1 (PD-1) and anti–programmed cell death-ligand 1 (PD-L1)) are approved as first- and second-line treatments for metastatic UC. PD-L1 expression levels in UC tumors help clinicians determine which patients are more likely to respond to IO therapies. Assays for approved IO agents use different antibodies, immunohistochemical protocols, cutoffs (defining “high” vs. “low” PD-L1 expression), and scoring algorithms. The robust control of pre-analytical and analytical standards is needed to obtain high-quality PD-L1 results. To better understand the status and perspectives of biomarker-guided patient selection for anti–PD-1 and anti–PD-L1 agents in UC, three workshops were held from December 2018 to December 2019 in Italy, Malaysia, and Spain. The primary goal was to develop recommendations for best practice approaches to PD-L1 testing in UC. Recommendations pertaining to the interpretation and reporting of the results of PD-L1 assays from experienced pathologists and oncologists from around the globe are included. A test request form for pathology laboratories was developed as a critical first step for oncologists/urologists to encourage communication between clinicians and pathologists, ensuring fast and high-quality test results. In this era of personalized medicine, we briefly discuss novel biomarkers being evaluated for IO agents in UC." @default.
- W3136760947 created "2021-03-29" @default.
- W3136760947 creator A5006249212 @default.
- W3136760947 creator A5048165263 @default.
- W3136760947 creator A5058161742 @default.
- W3136760947 creator A5072151730 @default.
- W3136760947 creator A5086028372 @default.
- W3136760947 date "2021-03-20" @default.
- W3136760947 modified "2023-10-16" @default.
- W3136760947 title "Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing" @default.
- W3136760947 cites W1705518899 @default.
- W3136760947 cites W1847493486 @default.
- W3136760947 cites W1971208896 @default.
- W3136760947 cites W1972882573 @default.
- W3136760947 cites W1975916903 @default.
- W3136760947 cites W1983093014 @default.
- W3136760947 cites W2035660473 @default.
- W3136760947 cites W2041435757 @default.
- W3136760947 cites W2093773243 @default.
- W3136760947 cites W2123638436 @default.
- W3136760947 cites W2275913223 @default.
- W3136760947 cites W2289712604 @default.
- W3136760947 cites W2462649057 @default.
- W3136760947 cites W2480996615 @default.
- W3136760947 cites W2559804019 @default.
- W3136760947 cites W2570190993 @default.
- W3136760947 cites W2588916311 @default.
- W3136760947 cites W2600167055 @default.
- W3136760947 cites W2612383893 @default.
- W3136760947 cites W2633073200 @default.
- W3136760947 cites W2655262992 @default.
- W3136760947 cites W2742288460 @default.
- W3136760947 cites W2747658619 @default.
- W3136760947 cites W2760106390 @default.
- W3136760947 cites W2760661635 @default.
- W3136760947 cites W2777192533 @default.
- W3136760947 cites W2785803176 @default.
- W3136760947 cites W2788431960 @default.
- W3136760947 cites W2790164909 @default.
- W3136760947 cites W2792667418 @default.
- W3136760947 cites W2792746202 @default.
- W3136760947 cites W2792856868 @default.
- W3136760947 cites W2794306956 @default.
- W3136760947 cites W2804019798 @default.
- W3136760947 cites W2806532569 @default.
- W3136760947 cites W2891732223 @default.
- W3136760947 cites W2891795654 @default.
- W3136760947 cites W2896603311 @default.
- W3136760947 cites W2897581535 @default.
- W3136760947 cites W2900738779 @default.
- W3136760947 cites W2902930155 @default.
- W3136760947 cites W2903620351 @default.
- W3136760947 cites W2913484031 @default.
- W3136760947 cites W2940349477 @default.
- W3136760947 cites W2944914845 @default.
- W3136760947 cites W2964014383 @default.
- W3136760947 cites W2965019135 @default.
- W3136760947 cites W2966465234 @default.
- W3136760947 cites W2971411777 @default.
- W3136760947 cites W2975441829 @default.
- W3136760947 cites W2975497362 @default.
- W3136760947 cites W2978508348 @default.
- W3136760947 cites W2985932098 @default.
- W3136760947 cites W2989713744 @default.
- W3136760947 cites W3005425311 @default.
- W3136760947 cites W3013054503 @default.
- W3136760947 cites W3019727209 @default.
- W3136760947 cites W3024551702 @default.
- W3136760947 cites W3026060226 @default.
- W3136760947 cites W3031433077 @default.
- W3136760947 cites W3032513350 @default.
- W3136760947 cites W3033203711 @default.
- W3136760947 cites W3033340144 @default.
- W3136760947 cites W3087464965 @default.
- W3136760947 cites W3087466624 @default.
- W3136760947 doi "https://doi.org/10.3390/cancers13061424" @default.
- W3136760947 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8003923" @default.
- W3136760947 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33804698" @default.
- W3136760947 hasPublicationYear "2021" @default.
- W3136760947 type Work @default.
- W3136760947 sameAs 3136760947 @default.
- W3136760947 citedByCount "18" @default.
- W3136760947 countsByYear W31367609472021 @default.
- W3136760947 countsByYear W31367609472022 @default.
- W3136760947 countsByYear W31367609472023 @default.
- W3136760947 crossrefType "journal-article" @default.
- W3136760947 hasAuthorship W3136760947A5006249212 @default.
- W3136760947 hasAuthorship W3136760947A5048165263 @default.
- W3136760947 hasAuthorship W3136760947A5058161742 @default.
- W3136760947 hasAuthorship W3136760947A5072151730 @default.
- W3136760947 hasAuthorship W3136760947A5086028372 @default.
- W3136760947 hasBestOaLocation W31367609471 @default.
- W3136760947 hasConcept C121608353 @default.
- W3136760947 hasConcept C126322002 @default.
- W3136760947 hasConcept C143998085 @default.
- W3136760947 hasConcept C177713679 @default.
- W3136760947 hasConcept C185592680 @default.
- W3136760947 hasConcept C19527891 @default.